Does telemedicine follow-up reduce medication adherence in rural primary-care patients? A cross-sectional survey
Published
January 21, 2024
Paper ID
PAP-000162
Status
Published
DOI
10.65712/tmj.test000420
Advance Services
Abstract
Background: Practice around telemedicine follow-up varies widely between centres. Methods: The primary outcome was medication adherence, assessed blind to allocation. Results: Effects were consistent across prespecified subgroups. 695 participants were included (median age 68 years). Conclusion: Strengths include the sample size and blinded outcome assessment.
Introduction
Guidelines make only a weak recommendation on telemedicine follow-up. The cost of medication adherence to health systems is substantial.
Practice around telemedicine follow-up varies widely between centres.
The cost of medication adherence to health systems is substantial. Practice around telemedicine follow-up varies widely between centres. medication adherence remains a leading cause of avoidable harm among rural primary-care patients.
The cost of medication adherence to health systems is substantial. medication adherence remains a leading cause of avoidable harm among rural primary-care patients.
Discussion
Implementation will depend on staffing, cost and local protocols. Residual confounding cannot be excluded.
These findings suggest that telemedicine follow-up is associated with better medication adherence in rural primary-care patients. Implementation will depend on staffing, cost and local protocols. Residual confounding cannot be excluded.
Strengths include the sample size and blinded outcome assessment. Residual confounding cannot be excluded. These findings suggest that telemedicine follow-up is associated with better medication adherence in rural primary-care patients.
Residual confounding cannot be excluded. Implementation will depend on staffing, cost and local protocols. Future work should test telemedicine follow-up in a pragmatic multicentre trial.
Strengths include the sample size and blinded outcome assessment. Residual confounding cannot be excluded.
Conclusions
Telemedicine follow-up should be considered for rural primary-care patients to improve medication adherence.
References
1. Yilmaz D, Herrera J, et al. Machine-learning triage and surgical site infection. BMC Med. 2018;259(11):539-1625.
2. Volkov Z, Lindqvist T, et al. SGLT2 inhibitors and medication adherence. Pediatrics. 2016;149(1):192-1120.
3. Patel B, Silva A, et al. SGLT2 inhibitors and health-related quality of life. BMC Med. 2022;220(9):87-1038.
4. Zhang Q, Nasser O, et al. Frailty screening and ventilator-free days. Ann Intern Med. 2015;259(4):769-1278.
5. Costa A, Okafor H, et al. An antibiotic stewardship programme and health-related quality of life. Ann Intern Med. 2025;159(9):804-1440.
6. Ahmed P, Haddad Y, et al. Nurse-led discharge planning and time to diagnosis. Eur Heart J. 2025;311(7):6-1770.
7. Zhang Z, Larsen X, et al. An enhanced recovery pathway and patient satisfaction. Lancet. 2022;279(5):28-963.
8. Nasser X, Silva B, et al. SGLT2 inhibitors and glycaemic control. N Engl J Med. 2012;264(11):42-1258.
Appendices
Ethics approval: IRB-8415.
Materials and Methods
We conducted a cross-sectional survey across 14 centres between 2017 and 2022. Eligible participants were rural primary-care patients.
Eligible participants were rural primary-care patients. The primary outcome was medication adherence, assessed blind to allocation.
Analyses were adjusted for age, sex and baseline severity. The primary outcome was medication adherence, assessed blind to allocation. We conducted a cross-sectional survey across 3 centres between 2020 and 2021.
Results
The adjusted odds ratio was 0.54 (95% CI 0.20 to 0.87). Serious adverse events were rare and similar between groups.
1795 participants were included (median age 32 years). Effects were consistent across prespecified subgroups.
medication adherence occurred in 14% of the intervention group versus 29% of controls. Serious adverse events were rare and similar between groups.
| Group | n | Events |
|---|---|---|
| Age < 65 | 36 | 45 |
| Age < 65 | 27 | 77 |
| Age ≥ 65 | 747 | 100 |
| Age ≥ 65 | 417 | 76 |
| Control | 868 | 103 |
Values are n (%) unless stated otherwise.

Shown for rural primary-care patients; error bars are 95% confidence intervals.
The adjusted odds ratio was 0.92 (95% CI 0.40 to 0.85). 2642 participants were included (median age 30 years).
medication adherence occurred in 18% of the intervention group versus 12% of controls. 822 participants were included (median age 36 years). medication adherence occurred in 10% of the intervention group versus 33% of controls.